Recent advances in pharmacokinetic modeling
β Scribed by Alaa M. Ahmad
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 139 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0142-2782
- DOI
- 10.1002/bdd.540
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
A major part of the science of pharmacokinetics is the modeling of the underlying processes that contribute to drug disposition. The purpose of pharmacokinetic models is to summarize the knowledge gained in preclinical and clinical studies at various stages in drug development and to rationally guide future studies with the use of adequately predictive models. This review highlights a variety of recent advances in mechanistic pharmacokinetic modeling. It is aimed at a broad audience, and hence, an attempt was made to maintain a balance between technical information and practical applications of pharmacokinetic modeling. It is hoped that drug researchers from all disciplines would be able to get a flavor of the function and capacity of pharmacokinetic modelers and their contribution to drug development. While this review is not intended to be a technical reference on modeling approaches, the roles of statistical applications and population methodologies are discussed where appropriate. Copyright Β© 2007 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
Clinical results of photodynamic therapy continue to show promise for the treatment of various solid malignancies. This paper briefly summarizes the advantages/disadvantages of various so-called βsecond-generationβ photosensitizers and other medical applications of porphyrin-based analogs.
Recent progress in antimicrobial dendrimers is reviewed. Both specific interactions and non-specific interactions can be utilized to design multifunctional (polyvalent) antimicrobial agents, which might be more potent than their mono-functional counterparts. Dendrimers or hyperbranched polymers can
Hepatic surgery has emerged over the last three decades and has proven to be a safe and effective treatment for primary and secondary malignancies, as well as for benign diseases of the liver. During the past 10 years, several major advances have been made in 1) surgical technique with the advent of